The Economic Impact of Pandemic Influenza in the United States: Priorities for Intervention

Abstract

We estimated the possible effects of the next influenza pandemic in the United States and analyzed the economic impact of vaccine-based interventions. Using death rates, hospitalization data, and outpatient visits, we estimated 89,000 to 207,000 deaths; 314,000 to 734,000 hospitalizations; 18 to 42 million outpatient visits; and 20 to 47 million additional illnesses. Patients at high risk (15% of the population) would account for approximately 84% of all deaths. The estimated economic impact would be US$71.3 to $166.5 billion, excluding disruptions to commerce and society. At $21 per vaccinee, we project a net savings to society if persons in all age groups are vaccinated. At $62 per vaccinee and at gross attack rates of 25%, we project net losses if persons not at high risk for complications are vaccinated. Vaccinating 60% of the population would generate the highest economic returns but may not be possible within the time required for vaccine effectiveness, especially if two doses of vaccine are required.

References 18

1. 1.

   Barker W. H. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health. 1986;76(7):761-765.

   Not in our library10.2105/ajph.76.7.761

2. 2.

   Barker W. H., Mullooly J. P. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112(6):798-811.

   Not in our library10.1093/oxfordjournals.aje.a113052

3. 3.

   Barker W. H., Mullooly J. P. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med. 1982;142(1):85-89.

   Not in our library

4. 4.

   Campbell D. S., Rumley M. H. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med. 1997;39(5):408-414.

   Not in our library10.1097/00043764-199705000-00006

5. 5.

   Carrat F., Valleron A. J. Influenza mortality among the elderly in France, 1980-90: how many deaths may have been avoided through vaccination? J Epidemiol Community Health. 1995;49(4):419-425.

   Not in our library10.1136/jech.49.4.419

6. 6.

   Cliff A. D., Haggett P. Statistical modelling of measles and influenza outbreaks. Stat Methods Med Res. 1993;2(1):43-73.

   Not in our library10.1177/096228029300200104

7. 7.

   Fox J. P., Hall C. E., Cooney M. K., Foy H. M. Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am J Epidemiol. 1982;116(2):212-227.

   Not in our library10.1093/oxfordjournals.aje.a113407

8. 8.

   Glezen W. P., Decker M., Joseph S. W., Mercready R. G. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis. 1987;155(6):1119-1126.

   Not in our library10.1093/infdis/155.6.1119

9. 9.

   Glezen W. P., Payne A. A., Snyder D. N., Downs T. D. Mortality and influenza. J Infect Dis. 1982;146(3):313-321.

   Not in our library10.1093/infdis/146.3.313

10. 10.
    The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable? · 1997

    No notice
11. 11.

    Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health. 1977;67(11):1063-1070.

    Not in our library10.2105/ajph.67.11.1063

12. 12.

    McBean A. M., Babish J. D., Warren J. L. The impact and cost of influenza in the elderly. Arch Intern Med. 1993;153(18):2105-2111.

    Not in our library

13. 13.

    Patriarca P. A., Arden N. H., Koplan J. P., Goodman R. A. Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine. Ann Intern Med. 1987;107(5):732-740.

    Not in our library10.7326/0003-4819-107-5-732

14. 14.

    Riddiough M. A., Sisk J. E., Bell J. C. Influenza vaccination. JAMA. 1983;249(23):3189-3195.

    Not in our library

15. 15.

    Schoenbaum S. C., McNeil B. J., Kavet J. The swine-influenza decision. N Engl J Med. 1976;295(14):759-765.

    Not in our library10.1056/nejm197609302951405

16. 16.

    Serfling R. E., Sherman I. L., Houseworth W. J. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963. Am J Epidemiol. 1967;86(2):433-441.

    Not in our library10.1093/oxfordjournals.aje.a120753

17. 17.

    Simonsen L., Clarke M. J., Schonberger L. B., Arden N. H., Cox N. J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53-60.

    Not in our library10.1086/515616

18. 18.

    Simonsen L., Clarke M. J., Williamson G. D., Stroup D. F., Arden N. H., Schonberger L. B. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87(12):1944-1950.

    Not in our library10.2105/ajph.87.12.1944

Cited by papers we hold 5

• Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review · 2018
  No notice
• Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses. · 2013
  Not checked
• Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment · 2011
  No notice
• Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza · 2009
  No notice
• Potential Impact of Antiviral Drug Use during Influenza Pandemic · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.